{"altmetric_id":1734537,"counts":{"readers":{"mendeley":21,"citeulike":0,"connotea":0},"total":{"posts_count":9},"twitter":{"unique_users_count":9,"unique_users":["BernardusMuller","jjyerbury","alsadvocacy","gln628","GreenJournal","NeuroWolfe","dmmcneice24","AngelasEcho","ALSToday"],"posts_count":9}},"selected_quotes":["Here's why we need more specialized trial centres in #ALS #MND"],"citation":{"abstract":"To investigate predictors of trial start-up times, high attrition, and poor protocol adherence in amyotrophic lateral sclerosis (ALS) trials.","abstract_source":"pubmed","altmetric_jid":"4f6fa5ea3cf058f610005b59","authors":["Nazem Atassi","Padmaja Yerramilli-Rao","Jackie Szymonifka","Hong Yu","Marianne Kearney","Daniela Grasso","Jing Deng","Mark Levine-Weinberg","Jordan Shapiro","Alexandra Lee","Lucia Joseph","Eric A. Macklin","Merit E. Cudkowicz"],"doi":"10.1212\/wnl.0b013e3182a823e0","first_seen_on":"2013-09-06T15:49:56+00:00","issns":["1526-632X"],"journal":"Neurology","last_mentioned_on":1381521672,"links":["http:\/\/www.neurology.org\/content\/early\/2013\/09\/04\/WNL.0b013e3182a823e0.abstract","http:\/\/www.neurology.org\/content\/81\/15\/1350"],"pdf_url":"http:\/\/www.neurology.org\/content\/early\/2013\/09\/04\/WNL.0b013e3182a823e0.full.pdf","pmid":"24005339","pubdate":"2013-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"},{"name":"Cognitive Science","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["neurology"],"title":"Analysis of start-up, retention, and adherence in ALS clinical trials","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/analysis-startup-retention-adherence-als-clinical-trials"},"altmetric_score":{"score":7,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7},"context_for_score":{"all":{"total_number_of_other_articles":6239510,"mean":5.9592213230259,"rank":809877,"this_scored_higher_than_pct":86,"this_scored_higher_than":5375299,"rank_type":"exact","sample_size":6239510,"percentile":86},"similar_age_3m":{"total_number_of_other_articles":104643,"mean":7.920632403815,"rank":17229,"this_scored_higher_than_pct":82,"this_scored_higher_than":86418,"rank_type":"exact","sample_size":104643,"percentile":82},"this_journal":{"total_number_of_other_articles":7888,"mean":12.270535564854,"rank":2193,"this_scored_higher_than_pct":70,"this_scored_higher_than":5587,"rank_type":"exact","sample_size":7888,"percentile":70},"similar_age_this_journal_3m":{"total_number_of_other_articles":41,"mean":12.53175,"rank":12,"this_scored_higher_than_pct":63,"this_scored_higher_than":26,"rank_type":"exact","sample_size":41,"percentile":63}}},"demographics":{"poster_types":{"member_of_the_public":4,"researcher":3,"practitioner":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Scientists":3,"Members of the public":4,"Practitioners (doctors, other healthcare professionals)":1,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Librarian":2,"Researcher":8,"Student  > Ph. D. Student":3,"Student  > Postgraduate":2,"Other":4,"Student  > Bachelor":2},"by_discipline":{"Engineering":1,"Medicine and Dentistry":8,"Neuroscience":1,"Social Sciences":4,"Psychology":2,"Computer Science":1,"Business, Management and Accounting":1,"Mathematics":1,"Unspecified":2}}},"geo":{"twitter":{"PT":1,"AU":2,"GB":1,"US":1,"IT":1},"mendeley":{"US":2,"MX":1,"FR":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/BernardusMuller\/status\/378048712049983488","license":"public","citation_ids":[1734537],"posted_on":"2013-09-12T06:53:31+00:00","author":{"name":"Bernardus Muller","url":"http:\/\/www.treeway.nl","image":"https:\/\/pbs.twimg.com\/profile_images\/2837088354\/eb7fcd185b28832b242f8b2f920facbe_normal.jpeg","description":"Biohero 2015. Patient 3.0, Advocate, fundraiser, drug developer & researcher all in #ALS One man can and will find a way, why not be that man...","id_on_source":"BernardusMuller","tweeter_id":"197747513","geo":{"lt":39.6945,"ln":-8.13057,"country":"PT"},"followers":7491},"tweet_id":"378048712049983488"},{"url":"http:\/\/twitter.com\/jjyerbury\/status\/378075651263057920","license":"public","rt":["BernardusMuller"],"citation_ids":[1734537],"posted_on":"2013-09-12T08:40:34+00:00","author":{"name":"Dr Justin Yerbury","url":"https:\/\/sites.google.com\/view\/yerburylab\/","image":"https:\/\/pbs.twimg.com\/profile_images\/631364535694196739\/29xG-NBa_normal.jpg","description":"Not that kind of doctor; A Wollongong local, a husband, a father, a cell biologist; trying to understand the molecular origins of Motor Neurone Disease.","id_on_source":"jjyerbury","tweeter_id":"1616597419","geo":{"lt":-34.424,"ln":150.89345,"country":"AU"},"followers":813},"tweet_id":"378075651263057920"},{"url":"http:\/\/twitter.com\/alsadvocacy\/statuses\/376009732382683137","license":"public","rt":["ALSToday"],"citation_ids":[1734537],"posted_on":"2013-09-06T15:51:20+00:00","author":{"name":"ALS Advocacy","url":"http:\/\/www.alsadvocacy.com","image":"https:\/\/pbs.twimg.com\/profile_images\/81737939\/alsadvocacytwitter_normal.jpg","description":"ALS = Lou Gehrig's Disease Thought it had been cured by now?   Still no known cause. Still no cure. Still no treatment. Still quickly fatal. Still outrageous.","id_on_source":"alsadvocacy","tweeter_id":"21649697","geo":{"lt":null,"ln":null},"followers":5856},"tweet_id":"376009732382683137"},{"url":"http:\/\/twitter.com\/gln628\/status\/378219708883140608","license":"public","rt":["BernardusMuller"],"citation_ids":[1734537],"posted_on":"2013-09-12T18:13:00+00:00","author":{"name":"davebridge","url":"http:\/\/t.co\/vlSrq5MH1b","image":"http:\/\/pbs.twimg.com\/profile_images\/437204045762412544\/bCBuHJTj_normal.jpeg","description":"in memory of Dave Bridge, co-founder @Finessewindows. My brave husband and best friend. Supporting research into Motor Neurone Disease.","id_on_source":"gln628","tweeter_id":"494396418","geo":{"lt":"52.4595363","ln":"-1.9503355","_id":"Harborne, Birmingham","country":"GB"},"followers":1140},"tweet_id":"378219708883140608"},{"url":"http:\/\/twitter.com\/GreenJournal\/status\/388741500865363968","license":"public","citation_ids":[1734537],"posted_on":"2013-10-11T19:02:50+00:00","author":{"name":"Neurology Journal","url":"http:\/\/www.aan.com\/go\/elibrary\/journal","image":"https:\/\/pbs.twimg.com\/profile_images\/474219235028107264\/2LOTXs2__normal.png","description":"Neurology is the most widely read and highly cited peer-reviewed neurology journal. It is the medical journal for the American Academy of Neurology.","id_on_source":"GreenJournal","tweeter_id":"59547205","geo":{"lt":44.97997,"ln":-93.26384,"country":"US"},"followers":25466},"tweet_id":"388741500865363968"},{"url":"http:\/\/twitter.com\/NeuroWolfe\/status\/388756185975128064","license":"public","rt":["GreenJournal"],"citation_ids":[1734537],"posted_on":"2013-10-11T20:01:12+00:00","author":{"name":"Francesco","url":"http:\/\/www.unifi.it\/p-doc2-2015-0-A-2c2a342a322c-1.html","image":"https:\/\/pbs.twimg.com\/profile_images\/948970881\/fotololli_normal.jpg","description":"Overweight Neurologist, obsessive scientist, clinical-solving doctor + witty professor (as judged by students, but essentially overrated)","id_on_source":"NeuroWolfe","tweeter_id":"19813406","geo":{"lt":43.76667,"ln":11.25,"country":"IT"},"followers":129},"tweet_id":"388756185975128064"},{"url":"https:\/\/twitter.com\/dmmcneice24\/status\/378049177420587008","license":"public","rt":["BernardusMuller"],"citation_ids":[1734537],"posted_on":"2013-09-12T06:55:22+00:00","author":{"name":"David McNeice ","url":"http:\/\/t.co\/JIan6COCYS","image":"http:\/\/pbs.twimg.com\/profile_images\/1681195170\/Mom_ALSwalk_normal.jpg","description":"Police Officer (Sergeant)\/ K-9 Handler, ran in the 2012 Boston Marathon for Team ALSMA.  Running in the 2013 Chicago Marathon for the ALS Association!","id_on_source":"dmmcneice24","tweeter_id":"399256360","geo":{"_id":"Work in East Windsor, CT"},"followers":400},"tweet_id":"378049177420587008"},{"url":"http:\/\/twitter.com\/AngelasEcho\/status\/380655047001911296","license":"public","rt":["BernardusMuller"],"citation_ids":[1734537],"posted_on":"2013-09-19T11:30:10+00:00","author":{"name":"Angela's Echo","url":"http:\/\/t.co\/yAiJCIVL","image":"http:\/\/si0.twimg.com\/profile_images\/3169675812\/471eb747e45950b254511df6625163c3_normal.jpeg","description":"Inspired by one woman's battle with Motor Neurone Disease (MND), Angela's Echo aims for a world that answers more questions than it asks about MND.","id_on_source":"AngelasEcho","tweeter_id":"1124867834","geo":{"lt":"-37.814","ln":"144.96332","country":"AU"},"followers":103},"tweet_id":"380655047001911296"},{"url":"http:\/\/twitter.com\/ALSToday\/statuses\/376009333667930112","license":"public","citation_ids":[1734537],"posted_on":"2013-09-06T15:49:45+00:00","author":{"name":"ALSToday","url":"http:\/\/www.als.net\/ALSToday","image":"http:\/\/pbs.twimg.com\/profile_images\/3338867444\/72db2375eab2bc0c8a1ff3bbb64b5f7c_normal.jpeg","description":"An online news magazine featuring the latest research advances and potential therapies for ALS.","id_on_source":"ALSToday","tweeter_id":"409518821","followers":910},"tweet_id":"376009333667930112"}]}}